Intensive care unit (ICU)-associated pressure injuries (PIs) represent a significant concern in critical care due to their impact on patient morbidity, length of stay, and healthcare costs. This review synthesizes recent advances in the prevention of PIs among ICU patients, emphasizing pathophysiological mechanisms, risk factors, diagnostic approaches, and evidence-based management strategies. Novel interventions, updated guidelines, and emerging technologies are discussed to offer clinicians an up-to-date resource for optimizing patient outcomes and minimizing harm in high-risk populations.
Pressure injuries, previously termed pressure ulcers or bedsores, are localized damage to the skin and underlying tissue resulting primarily from sustained pressure or pressure combined with shear. ICU patients are at heightened risk due to immobility, hemodynamic instability, and the frequent presence of multiple comorbidities. Despite preventive efforts, the incidence of ICU-associated PIs remains a challenge, necessitating ongoing research and implementation of novel strategies to improve patient care.
The prevalence of pressure injuries in the ICU setting ranges from 10% to 30%, with some studies reporting even higher rates in specific high-risk populations. ICU-acquired PIs are associated with increased morbidity, longer hospital stays, higher treatment costs, and a greater risk of secondary infections. The burden is magnified by factors such as advanced patient age, severity of illness, and hospital resource constraints, making prevention a key quality indicator in critical care.
The development of pressure injuries is a multifactorial process driven by prolonged mechanical loading, leading to localized ischemia, tissue deformation, and ultimately cell death. In ICU patients, additional contributing factors include impaired perfusion due to vasopressors, systemic inflammation, edema, and hypoxia. Shear forces, moisture, and temperature fluctuations further exacerbate tissue vulnerability. Understanding the interplay of these mechanisms is crucial for targeted prevention strategies.
Major risk factors for ICU-associated PIs include immobility, reduced consciousness, poor nutritional status, mechanical ventilation, incontinence, and the use of medical devices (e.g., endotracheal tubes, catheters, and monitoring equipment). The Braden Scale and other risk assessment tools are widely used to stratify patients, but ongoing research suggests that dynamic, real-time risk assessment may be superior in rapidly changing ICU environments.
Clinical presentation of pressure injuries ranges from non-blanchable erythema (Stage 1) to full-thickness tissue loss with exposure of muscle, tendon, or bone (Stage 4). Device-related pressure injuries may have atypical locations and irregular shapes. Early recognition is critical, as prompt intervention can prevent progression to more severe stages, which are associated with adverse outcomes.
Diagnosis is primarily clinical, based on visual inspection and palpation of at-risk skin areas. Adjunctive tools such as subepidermal moisture measurement, ultrasound, and thermography have emerged to support early detection. Documentation and staging according to standardized criteria (e.g., National Pressure Injury Advisory Panel) are essential for guiding management and benchmarking quality improvement efforts.
Management strategies for pressure injuries focus on relieving pressure, optimizing nutrition, maintaining skin integrity, and treating underlying medical conditions. Positioning protocols, specialized support surfaces, and frequent skin assessments form the backbone of prevention. Wound care protocols vary depending on the stage and extent of injury, but generally include cleansing, debridement, moisture balance, and infection control. Multidisciplinary involvement—particularly wound care specialists, nutritionists, and physical therapists—improves outcomes.
Recent advances in ICU PI prevention include the use of high-specification foam and dynamic air mattresses, microclimate management devices, and continuous bedside pressure mapping systems. Antimicrobial dressings and topical agents have shown promise in select settings. Artificial intelligence and machine learning models are being developed to predict risk in real time, facilitating prompt intervention. Additionally, early mobilization programs and targeted staff education have demonstrated efficacy in reducing incidence rates. Some centers have implemented bundled care approaches that synergize multiple preventive measures, leading to significant improvements in patient safety metrics.
Current guidelines from organizations such as the National Pressure Injury Advisory Panel and European Pressure Ulcer Advisory Panel recommend comprehensive risk assessment on ICU admission and at regular intervals, implementation of individualized repositioning schedules, use of advanced support surfaces, moisture management, and prompt intervention upon early signs of PI development. Education of staff and ongoing quality improvement initiatives are emphasized as integral components of an effective prevention program. Recent updates also support the use of technology-assisted assessment and documentation to enhance consistency and accuracy in care delivery.
ICU-associated pressure injuries remain a significant clinical challenge, but ongoing advances in prevention, diagnosis, and management offer promising avenues to mitigate risk and improve patient outcomes. Adoption of evidence-based protocols, integration of emerging technologies, and multidisciplinary collaboration are essential for sustaining progress. Continued research and innovation will be crucial as critical care environments evolve and patient populations become increasingly complex.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation